1. |
Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology, 2017, 88(3): 296-303.
|
2. |
Hurt E, Arnold LE, Lofthouse N. Quantitative EEG neurofeedback for the treatment of pediatric attention-deficit/hyperactivity disorder, autism spectrum disorders, learning disorders, and epilepsy. Child Adolesc Psychiatr Clin N Am, 2014, 23(3): 465-486.
|
3. |
Berg AT, Plioplys S, Tuchman R. Risk and correlates of autism spectrum disorder in children with epilepsy: a community based study. J Child Neurol, 2011, 26(5): 540-547.
|
4. |
Fisher B, Dezort C, Nordli DR, et al. Routine developmental and autism screening in an epilepsy care setting. Epilepsy Behav, 2012, 24(4): 488-492.
|
5. |
Amiet C, Gourfinkel-An I, Laurent C, et al. Epilepsy in simplex autism pedigrees is much lower than the rate in multiplex autism pedigrees. Biol Psychiatry, 2013, 74(3): e3-e4.
|
6. |
Hughes JR, Melyn M. EEG and seizures in autistic children and adolescents: further findings with therapeutic implications. Clin EEG Neurosci, 2005, 36(1): 15-20.
|
7. |
Berg AT, Plioplys S. Epilepsy and autism: Is there a special relationship? Epilepsy Behav, 2012, 23(3): 193-198.
|
8. |
杨志仙, 刘晓燕, 张月华, 等. Angelman 综合征临床及脑电图特点. 中国实用儿科杂志, 2011, 26(7): 519-523.
|
9. |
中华医学会儿科学分会内分泌遗传代谢学组. 中国Prader-Willi综合征诊治专家共识(2015). 中华儿科杂志, 2015, 53(6): 419-421.
|
10. |
Soppa U, Schumacher J, Florencio Ortiz V, et al. The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation. Cell Cycle, 2014, 13(13): 2084-2100.
|
11. |
Arya R, Kabra M, Gulati S. Epilepsy in children with Down syndrome. Epileptic Disord, 2011, 13(1): 1-7.
|
12. |
Wilson HL, Wong AC, Shaw SR, et al. Molecular characterization of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet, 2003, 40(8): 575-584.
|
13. |
Delahanty RJ, Zhang Y, Bichell TJ, et al. Beyond Epilepsy and Autism: Disruption of GABRB3 Causes Ocular Hypopigmentation. Cell Rep, 2016, 17(12): 3115-3124.
|
14. |
Andrew G. McKechanie, Sonya Campbell, Sarah E. A. Eley, et al Autism in Fragile X Syndrome; A Functional MRI Study of Facial Emotion-Processing. Genes, 2019, 10(12): 1052.
|
15. |
Blackmon K, Bluvstein J, MacAllister WS, et al. Treatment Resistant Epilepsy in Autism Spectrum Disorder: Increased Risk for Females. Autism Res, 2016, 9(2): 311-320.
|
16. |
Bernardo Pia; Cobb Stuart; Coppola Antonietta, et al. Neurophysiological Signatures of Motor Impairment in Patients with Rett Syndrome. Annals of neurology, 2020, 87: 763-773.
|
17. |
梅道启; 符娜; 秦炯. 结节性硬化症TSC1、TSC2基因型与临床表型研究进展. 中国实用儿科杂志, 2019, 34(4): 309-313.
|
18. |
田小娟, 张月华, 杨小玲, 等. 家族性Dravet综合征家系临床表型特点和基因突变研究. 中华实用儿科杂志, 2016, 31(20): 1531-1535.
|
19. |
曾琦, 张月华, 杨小玲, 等. 良性家族性婴儿癫痫的致病基因谱研究. 中华实用儿科临床杂志, 2017, 32(24): 1866-1872.
|
20. |
刘爱杰, 许小菁, 孙丹, 等. 原钙黏蛋白19基因相关癫痫的遗传特点及临床表型谱研究. 癫痫杂志, 2017, 3(4): 283-291.
|
21. |
Dedek K, Fusco L, Teloy N, et al. Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2. Epilepsy Res, 2003, 54(1): 21-27.
|
22. |
Saitsu Hirotomo, Kato Mitsuhiro, Koide Ayaka, et al. Whole exome sequencing identifies KCNQ2 mutations in Ohtahara syndrome. Annals of neurology, 2012, 72(2): 298-300.
|
23. |
曾琦, 张月华, 杨小玲, 等. KCNQ2基因突变相关癫痫的临床表型谱研究. 癫痫杂志, 2019, 5(4): 244-256.
|
24. |
Tao J, Van Esch H, Hagedorn-Greiwe M, et al. Mutations in the X-linked cyclin-dependent kinase-like 5(CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet, 2004, 75(6): 1149-54.
|
25. |
Bahi-Buisson N, Nectoux J, Rosas-Vargas H, et al. Key clinical features to identify girls with CDKL5 mutations. Brain, 2008, 131(Pt 10): 2647-2661.
|
26. |
章清萍, 赵澄, 包新华, 等. 早发性癫痫脑病患儿的CDKL5基因突变特点与临床特征. 中华医学遗传学杂志, 2016, 33(3): 404-407.
|
27. |
Yang Y, Shen W, Ni Y, et al. Impaired Interneuron Development after Foxg1 Disruption. Cereb Cortex, 2017, 27(1): 793-808.
|
28. |
G Lesca, G Rudolf, A Labalme, et al. Epileptic encephalopathies of the Landau-Kleffner and continuous spike and waves during slow-wave sleep types: Genomic dissection makes thelink with autism. Epilepsia, 2012, 53(9): 1526-1538.
|
29. |
Viscidi EW, Triche EW, Pcscosolido MF, et al. Clinical characteristics of children with autism spectrum disorder and cooccurring epilepsy. PloS one, 2013, 8(7): e67797.
|
30. |
Chénier S, Yoon G. CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems. J Neurodev Disord, 2014, 6(1): 9.
|
31. |
Lund C, Brodtkorb E, Øye AM, et al. CHD2 mutations in Lennox-Gastaut syndrome. Epilepsy Behav, 2014, 33: 18-21.
|
32. |
Carvill GL, Heavin SB. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nature Genetics, 2013, 45(7): 825-830.
|
33. |
Suls A, Jaehn JA, Kecskés A, et al. De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome. American Journal of Human Genetics, 2013, 93(5): 967-975.
|
34. |
Neeraj Singh, Anthony Ritaccio. Juvenile myoclonic epilepsy mimic associated with CHD2 gene mutation. Epilepsy & behavior reports, 2020, 13: 100355.
|
35. |
Iossifov I, O'Roak BJ. The contribution of de novo CO2Ding mutations to autism spectrum disorder. Nature, 2014, 515(7526): 216-221.
|
36. |
Valik D, Miner PT, Jones JD. First U.S. case of adenylosuccinate lyase deficiency with severe hypotonia. Pediatr Neurol, 1997, 16(3): 252-255.
|
37. |
Macchiaiolo M, Barresi S, Cecconi F, et al. A mild form of adenylosuccinate lyase deficiency in absence of typical brain MRI features diagnosed by whole exome sequencing. Ital J Pediatr, 2017, 43(1): 65.
|
38. |
Pérez-Dueñas B, Sempere A, Campistol J, et al. Novel features in the evolution of adenylosuccinate lyase deficiency. Eur J Paediatr Neurol, 2012, 16(4): 343-348.
|
39. |
Edery P, Chabrier S, Ceballos-Picot I, et al. Intrafamilial variability in the phenotypic expression of adenylosuccinate lyase deficiency: a report on three patients. Am J Med Genet A, 2003, 120(2): 185-190.
|
40. |
Jurecka A, Jurkiewicz E, Tylki-Szymanska A. Magnetic resonance imaging of the brain in adenylosuccinate lyase deficiency: a report of seven cases and a review of the literature. Eur J Pediatric, 2012, 171(1): 131-138.
|
41. |
康天, 陈娇阳, 张月华. 腺苷琥珀酸裂解酶缺乏症3例报告并文献复习. 中国实用儿科杂志, 2020, 35(4): 315-318.
|
42. |
Berryer MH, Hamdan FF, Klitten LL, et al. Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency. Hum Mutat, 2013, 34(2): 385-394.
|
43. |
Mignot C, von Stülpnagel C, Nava C, et al. Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy. J Med Genet, 2016, 53(8): 511-522.
|
44. |
von Stülpnagel C, Claudia Funke, Caroline Haberl, et al. SYNGAP1 mutation in focal and generalized epilepsy: a literature overview and a case report with special aspects of the EEG. Neuropediatrics, 2015, 46(4): 287-291.
|
45. |
Miyake K, Hirasawa T, Koide T, et al. Epigenetics in autism and other neurodevelopmental diseases. Adv Exp Med Biol, 2012, 724: 91-98.
|
46. |
张仪, 姚如恩, 胥雨菲. CASK基因变异1例临床特征分析. 临床儿科杂志, 2019, 37(9): 693-696.
|
47. |
Getz SA, DeSpenza T Jr, Li M, et al. Rapamycin prevents, but does not reverse, aberrant migration in PTEN knockout neurons. Neurobiol Dis, 2016, 93: 12-20.
|
48. |
He X, Thacker S, Romigh T, et al. Cytoplasm-predominant Pten associates with increased region-specific brain tyrosine hydroxylase and dopamine D2 receptors in mouse model with autistic traits. Mol Autism, 2016, 3(7): 14.
|
49. |
陆颖, 张晨, 易正辉, 等. PTEN基因在神经疾病发病机制中作用的研究进展. 精神医学杂志, 2016, 29(5): 388-391.
|